These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 16816557
1. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, Novitsky V, Makhema J, Lagakos S, Essex M. AIDS; 2006 Jun 12; 20(9):1281-8. PubMed ID: 16816557 [Abstract] [Full Text] [Related]
2. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L. J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114 [Abstract] [Full Text] [Related]
3. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F. Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758 [Abstract] [Full Text] [Related]
4. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F. PLoS Med; 2007 Aug 15; 4(8):e257. PubMed ID: 17713983 [Abstract] [Full Text] [Related]
5. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV. Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW. Clin Infect Dis; 2009 Jul 15; 49(2):299-305. PubMed ID: 19522656 [Abstract] [Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe. Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M. Clin Infect Dis; 2007 Jan 01; 44(1):111-9. PubMed ID: 17143826 [Abstract] [Full Text] [Related]
7. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire. Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ. AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864 [Abstract] [Full Text] [Related]
8. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. Shapiro RL, Holland DT, Capparelli E, Lockman S, Thior I, Wester C, Stevens L, Peter T, Essex M, Connor JD, Mirochnick M. J Infect Dis; 2005 Sep 01; 192(5):720-7. PubMed ID: 16088821 [Abstract] [Full Text] [Related]
9. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast. Ekouevi DK, Touré R, Becquet R, Viho I, Sakarovitch C, Rouet F, Towne-Gold B, Fassinou P, Leroy V, Blanche S, Dabis F, Agence Nationale de Recherches Sur le SIDA 1201/1202 Ditrame Plus Study Group. Pediatrics; 2006 Oct 01; 118(4):e1071-7. PubMed ID: 16950945 [Abstract] [Full Text] [Related]
10. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators. J Infect Dis; 2003 Mar 01; 187(5):725-35. PubMed ID: 12599045 [Abstract] [Full Text] [Related]
11. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team. JAMA; 2006 Aug 16; 296(7):794-805. PubMed ID: 16905785 [Abstract] [Full Text] [Related]
12. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N. Am J Obstet Gynecol; 2007 Sep 16; 197(3 Suppl):S42-55. PubMed ID: 17825650 [Abstract] [Full Text] [Related]
13. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. TEmAA ANRS 12109 Study group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouévi DK, Dabis F. AIDS; 2009 Apr 27; 23(7):825-33. PubMed ID: 19307941 [Abstract] [Full Text] [Related]
14. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1. Eshleman SH, Hoover DR, Hudelson SE, Chen S, Fiscus SA, Piwowar-Manning E, Jackson JB, Kumwenda NI, Taha TE. J Infect Dis; 2006 Feb 15; 193(4):479-81. PubMed ID: 16425125 [Abstract] [Full Text] [Related]
15. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Kesho Bora Study Group, de Vincenzi I. Lancet Infect Dis; 2011 Mar 15; 11(3):171-80. PubMed ID: 21237718 [Abstract] [Full Text] [Related]
16. A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe. Zijenah LS, Kadzirange G, Rusakaniko S, Kufa T, Gonah N, Tobaiwa O, Gwanzura C, Matsikire E, Katzenstein DA. Cent Afr J Med; 2006 Mar 15; 52(1-2):1-8. PubMed ID: 17892232 [Abstract] [Full Text] [Related]
17. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394 [Abstract] [Full Text] [Related]
18. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso. Kouanda S, Tougri H, Cisse M, Simpore J, Pietra V, Doulougou B, Ouedraogo G, Ouedraogo CM, Soudre R, Sondo B. AIDS Care; 2010 Jul 06; 22(7):843-50. PubMed ID: 20635248 [Abstract] [Full Text] [Related]
19. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL. N Engl J Med; 1994 Nov 03; 331(18):1173-80. PubMed ID: 7935654 [Abstract] [Full Text] [Related]
20. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges. Kesho Bora Study Group. Contemp Clin Trials; 2011 Jan 03; 32(1):74-85. PubMed ID: 20854932 [Abstract] [Full Text] [Related] Page: [Next] [New Search]